Pharmaceutical Company CEO Developing $100 Alternative To EpiPen After 'Shameful' Price Hike
September 4, 2016
Mark Baum, CEO of Imprimis Pharmaceuticals who previously came out with a $1 alternative to Martin Shkreli's AIDS drug after 5000% price hike, is now going to take on Mylan and is plotting to offer a $100 EpiPen alternative.
Mark Baum / Imprimis Pharmceuticals
Baum believes the relentless EpiPen price hikes are "shameful" and plans to have a compounded version of the allergy treatment by the end of the year.
"I don't need to make $19 million a year," Baum said, referring to the big pay package Mylan's CEO Heather Bresch took home last year.
"Tonight when I go home I'm going to eat a nice piece of fish and the fish I eat isn't any better or worse than what she is going to eat."
Click Here For The Most Popular On Sunny Skyz
Drive-Thru Safari Surprise: Woman Gets Up Close And Personal With Scottish Highland Cow
This High School Tradition Is Bringing Millions To Tears - The Teachers' Reactions Are Everything
This Magician's Mind-Bending Halloween Costume Has The Internet Stumped
Dad Builds Incredible 65-Foot Pirate Ship Playset For His Kids
Over 130,000 Men Described The Woman They Love. Here Are The 15 Most Heartfelt Responses
ER Physician Assistant Gets A Heartwarming Gift That Turns His Night Around
Drummer's Unexpected Cartoon Sound Effect Has Lead Singer 'Fighting For His Life' On Stage
She Dressed As Her Coworker And He Could Not Stop Laughing
Mom's Hilarious Parody Of Fitness Advice Is All Too Relatable
This Toddler's Grandpa Is A Triplet. Her Name For All Of Them Is Going Viral
Doorbell Camera Captures Heart-Stopping Moment Illinois Neighbor Saves Choking Child